Variant report
Variant | esv3474616 |
---|---|
Chromosome Location | chr6:79521733-79530731 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:10)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:10 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:79528045-79528073 | IMR90 | lung: | n/a | n/a |
2 | CEBPD | chr6:79529447-79529729 | K562 | blood: | n/a | n/a |
3 | CTCF | chr6:79526849-79526879 | LNCaP | prostate: | n/a | n/a |
4 | E2F4 | chr6:79522269-79522469 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | GATA2 | chr6:79522643-79523186 | HUVEC | blood vessel: | n/a | n/a |
6 | GATA3 | chr6:79529418-79529768 | MCF-7 | breast: | n/a | n/a |
7 | POLR2A | chr6:79526013-79526030 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr6:79524028-79524173 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | STAT3 | chr6:79525384-79525549 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | STAT3 | chr6:79524978-79525070 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:79522220..79524770-chr6:79527033..79529117,2 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PHIP-1 | chr6:79519432-79521881 | XLOC_005771 |
2 | lnc-PHIP-1 | chr6:79522839-79523020 | XLOC_005771 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229495 | TF binding region |
ENSG00000229495 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557614797 | chr6:79521745-79521746 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs577814898 | chr6:79521757-79521758 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs541391926 | chr6:79521774-79521775 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs564868955 | chr6:79521775-79521776 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs537101685 | chr6:79521781-79521782 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs184290068 | chr6:79521797-79521798 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs578120266 | chr6:79521806-79521807 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs573658395 | chr6:79521825-79521826 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs377757531 | chr6:79521826-79521827 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs542591328 | chr6:79521831-79521832 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs559589028 | chr6:79521862-79521863 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs573004088 | chr6:79521865-79521866 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs545194846 | chr6:79521871-79521872 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs564699147 | chr6:79521889-79521890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530929492 | chr6:79521929-79521930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187876155 | chr6:79521954-79521955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560972342 | chr6:79521975-79521976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140870377 | chr6:79521998-79521999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547016598 | chr6:79522004-79522005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs563851004 | chr6:79522054-79522055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370921158 | chr6:79522065-79522066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375340819 | chr6:79522090-79522091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530605699 | chr6:79522100-79522101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532649309 | chr6:79522102-79522103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs552813406 | chr6:79522128-79522129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569437630 | chr6:79522130-79522131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs537173171 | chr6:79522144-79522145 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6454086 | chr6:79522163-79522164 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs192488458 | chr6:79522169-79522170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs540142830 | chr6:79522181-79522182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184651011 | chr6:79522182-79522183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372011981 | chr6:79522197-79522198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189212961 | chr6:79522208-79522209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544942263 | chr6:79522225-79522226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs558354611 | chr6:79522241-79522242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs111782885 | chr6:79522246-79522247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79254459 | chr6:79522264-79522265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs544331974 | chr6:79522298-79522299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561033736 | chr6:79522319-79522320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs530083707 | chr6:79522329-79522330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374000541 | chr6:79522354-79522355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150120184 | chr6:79522381-79522382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs138539893 | chr6:79522405-79522406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552883219 | chr6:79522410-79522411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149399717 | chr6:79522469-79522470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531933849 | chr6:79522513-79522514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550742036 | chr6:79522516-79522517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113889413 | chr6:79522520-79522521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567360716 | chr6:79522538-79522539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs56176829 | chr6:79522654-79522655 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
Breast cancer | 17133270 | CNVD |
Leukemia | 18688285 | CNVD |
Prostate cancer | 19242612 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Lung cancer | 16773561 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Prostate cancer | 16461572 | CNVD |
Mental retardation | 21045960 | CNVD |
Obesity | 21045960 | CNVD |
learning difficulties | 21045960 | CNVD |
Prostate cancer | 17245344 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:79519000-79521800 | Enhancers | HMEC | breast |
2 | chr6:79519200-79521800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr6:79519200-79521800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr6:79521400-79522600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:79521800-79522800 | Weak transcription | HMEC | breast |
6 | chr6:79521800-79527000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr6:79522800-79523000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr6:79522800-79523000 | Enhancers | HMEC | breast |